Real-time enrollment status for this focal seizures clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 5:24 PM UTC
| NCT Number | NCT07233239 |
| Recruiting Status | Recruiting |
| Condition | Focal Seizures |
| Phase | PHASE1 |
| Target Enrollment | 100 participants |
| Active Locations | 24 sites in the US |
| Sponsor | Jazz Pharmaceuticals |
| Last Updated on CT.gov | August 11, 2026 (2 weeks ago) |
As of August 27, 2026: Clinical trial NCT07233239 is currently recruiting participants. This phase1 study for focal seizures is actively seeking new participants at 24 locations across the United States. The study is sponsored by Jazz Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07233239 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07233239 was last updated 2 weeks ago (August 11, 2026). HelloStudys verifies this status automatically.